Safety and Feasibility of Dobutamine-Atropine Stress Testing in Hypertensive Patients
作者:
Abdou Elhendy,
Ron T. van Domburg,
Jos R.T.C. Roelandt,
Marcel L. Geleijnse,
M. Mohsen Ibrahim,
Paolo M. Fioretti,
期刊:
Hypertension
(OVID Available online 1997)
卷期:
Volume 29,
issue 6
页码: 1232-1239
ISSN:0194-911X
年代: 1997
出版商: OVID
数据来源: OVID
摘要:
40 mm Hg) during the test was more frequent in hypertensive patients (7% versus 4% in normotensive, P < .05). Independent predictors of hypotension were baseline systolic pressure greater than 140 mm Hg (odds ratio, 6.9; 95% confidence interval, 3.4 to 14), older age (odds ratio, 1.04; 95% confidence interval, 1.01 to 1.07), and medication with calcium channel blockers (odds ratio, 1.8; 95% confidence interval, 1.1 to 3.5). The prevalence of ventricular tachycardia was similar (4.1%) in both groups. Episodes of 10 beats or more (0.06% of patients) were terminated promptly by intravenous metoprolol administration. Dobutamine stress testing was considered feasible in 91% of patients with and 92% of patients without hypertension. Dobutamine-atropine stress echocardiography is a safe and feasible method for the assessment of hypertensive patients referred for evaluation of myocardial ischemia. Despite the higher prevalence of dobutamine-induced hypotension in these patients, the feasibility of the test is comparable to that in individuals without hypertension. (Hypertension. 1997;29:1232-1239.)
返 回